Pre-clinical models of infectious diseases - task areas a and b
Ended Awarded Last action
- Contract number
- 75N93024D00015
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Pre-Clinical Models of Infectious Diseases Pre-Solicitation · NIHAI75N93023R00003 · Posted Oct 21, 2022
- Last date to order 100% complete
- IDV ceiling
- $146,300,000.00
- Maximum order
- $146,300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 76 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Midwest Research Institute (doing business as Mriglobal) aims to provide pre-clinical evaluation of infectious disease countermeasures. The $146.3 million single-award IDC has a period of performance through August 2024.
The contract covers the development and refinement of small animal, non-human primate, and animal replacement/non-traditional models to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of candidate vaccines, therapeutics, and diagnostics targeting priority infectious disease areas. These include RNA viruses with pandemic potential, antimicrobial resistant infections, emerging/re-emerging infectious diseases, neglected tropical diseases, and sexually transmitted infections. The contract also includes the generation and distribution of specialized infectious disease research reagents. This IDC is expected to support NIAID's mission of advancing critical medical countermeasures through the product development pipeline.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93024D00015?
75N93024D00015 was awarded to Mriglobal by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.
How much is contract 75N93024D00015 worth?
75N93024D00015's own ceiling is $146,300,000. A single order can be worth up to $146,300,000.
Who can order from contract 75N93024D00015?
75N93024D00015 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93024D00015 part of a contract vehicle?
Yes. 75N93024D00015 is part of Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024D00015 competed?
The extent of competition for 75N93024D00015 was full and open competition. The government received 76 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV